Within the type dimension of Lip Volumizer segmentation, four sub‑categories dominate: hyaluronic acid‑based, collagen‑based, synthetic polymer‑based, and autologous‑fat formulations. Hyaluronic acid (HA) products command the largest share owing to their reversible nature, favorable safety profile, and ease of injection, which translates into higher unit sales and premium pricing. Collagen‑based fillers, while historically significant, now occupy a modest niche because of immunogenic concerns and the rise of HA alternatives. Synthetic polymer fillers, such as poly‑L‑lactic acid, serve a specialized segment seeking longer‑lasting volumization, contributing a mid‑range share that balances higher cost against extended durability. Autologous‑fat injections, derived from the patient’s own tissue, represent the smallest yet clinically important slice, limited by procedural complexity and variable graft retention. Each type’s distinct performance characteristics and regulatory status determine its proportional impact on total market volume, with HA‑based products driving the bulk of growth while niche types sustain diversified revenue streams.